Upadacitinib for the treatment of psoriatic arthritis

Diogo Fonseca, Miguel Nogueira, Tiago Torres

Article Type

Review

Published

This article offers a review of the more recently published results on the Janus kinase inhibitor inhibitor upadacitinib and its use in the treatment of psoriatic arthritis.

Read more

Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis

Martina Biggioggero MD, Andrea Becciolini MD, Chiara Crotti MD, Elena Agape MD, Ennio Giulio Favalli MD

Article Type

Review

Published

This narrative review discusses the rationale for JAK inhibition in RA, with a special focus on the role of JAK1 selective blockade and a detailed description of available data from the results of clinical trials on upadacitinib and filgotinib.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.